YSYasmine Gamal Sabry

Yasmine Gamal Sabry

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yasmine Gamal Sabry has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Abeer A. K. Mohamed

    Department of Human Anatomy, College of Medicine, Jazan University

    1 shared publication
  • Amira H. Eltrawy

    Department of anatomy and embryology, faculty of medicine, alexandria university

    1 shared publication
  • Amr Elmistekawy

    Department of Internal Medicine, Gastroenterology Division, Faculty of Medicine, Al-Azhar University

    1 shared publication
  • Azza Hassan Abou Ghalia

    Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Egypt

    1 shared publication
  • Dina M. Khodeer

    Department of Pharmacology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU)

    1 shared publication
  • Isra Omar

    Department of Clinical Medicine, College of Medicine, Almaarefa University

    1 shared publication

Latest Publications

  • Open Access

    Calycosin protects from histopathological and ultrastructural changes in ethanol-induced liver injury and exhibits predicted binding affinity to TNF-α/NF-κB/HIF-1α proteins

    by Abeer A. K. Mohamed, Yasmine G. Sabry, Amr Elmistekawy, Tahani Saaedi, Isra Omar, Sawsan A. Zaitone, Noura Moustafa Mohamed, Dina M. Khodeer, Amira H. Eltrawy

    Background/objectives: Liver fibrosis is the consequence of the wound-healing response of the liver to frequent injury. Calycosin is a flavonoid, which has been documented for its hepatoprotective properties. The aim of this study was to evaluate the hepatoprotective action of calycosin in a model of ethanol-induced liver injury (EILI) in rats. For mechanistic insights, we aimed to measure tumor necrosis factor-α (TNF-α), nuclear factor-κB (NF-κB), and hypoxia-inducible factor-1 alpha (HIF-1α) protein levels in liver samples and evaluate the ability of calycosin to bind these pathologic molecules. Methods: Network pharmacology and molecular docking were performed for discovering the interacting target proteins. Forty male rats were assigned into five groups: 1) the vehicle, 2) the calycosin per se group, 3) the EILI control group, and 4) and 5) the EILI + calycosin (5 or 10 mg/kg) groups. The liver homogenates were used for ELISA measurement of TNF-α, NF-κB, and HIF-1α. Furthermore, liver specimens were used for histopathological and ultrastructural investigations. Results: The network pharmacology study confirmed the role of TNF-α/NF-κB/HIF-1α signaling in EILI, and molecular docking explored the possible interaction between calycosin and these three molecules (docking score = −7.6, −7, and −7.6 kcal/mol). The rat study showed that calycosin was able to attenuate histopathological and ultrastructural changes in rat livers, reduce collagen accumulation, and prevent the increases shown in liver enzyme activities (2.17-fold for ALT and 2.26-fold for AST). Conclusion: Thus, these integrated in silico and in vivo studies confirmed the hepatoprotective effect of calycosin against the EILI rat model and provided a mechanistic insight through TNF-α/NF-κB/HIF-1α signaling. Further studies are warranted to fully explore the protective mechanism of calycosin in EILI.

  • Effect of apigenin on dynamin-related protein 1 in type 1 diabetic rats with cardiovascular complications

    by Sara Gamal Sherif, Marwa Tarek, Yasmine Gamal Sabry, Azza Hassan Abou Ghalia